Design case study · Sarmad Mughal
Nugevia: product clarity across different creative directions.
This portfolio work explores product-led and human-led layouts for Nugevia. The focus here is how the designs communicate, rather than making claims about supplement efficacy or campaign performance.
Discuss your project →
Direction one: let the product lead
The MND product-hero creative uses a centred pack and a symmetrical platform to make the product easy to recognise. Blue tones connect the setting to the packaging. The layout gives the headline and product space instead of trying to include every detail in the same frame.
Direction two: introduce human context
The PWR creative includes a person holding the product. This changes the visual entry point from a studio product display to a person and product together. It creates another direction for the creative team to explore while keeping the packaging visible.
Managing information density
Other MND portfolio variations include ingredient information, benefit icons and product differentiation. Extra detail can help explain an unfamiliar product, but it competes for attention. At mobile size I would review whether the main message remains clear before adding another supporting point.
What I would test next
I would compare the product-led composition with a warmer human-context direction while keeping the offer consistent. For layouts with more supporting information, I would test one approved benefit per variation. These suggestions describe a testing approach; they do not imply either layout has already outperformed another.
Deliverables and takeaway
The two displayed examples are a product-led MND execution and a human-led PWR execution. Product recognition remains important in both. Treat these as examples of visual direction rather than proof of efficacy or advertising results. A new project should agree its own claims, formats and deliverable list.
Evidence and limits
The original portfolio breakdown records positive client feedback for the work. That supports client satisfaction, not an advertising performance claim. I do not have campaign-level CTR, acquisition-cost or ROAS data for these creatives. Any health-related messaging in new work needs the brand’s evidence and approval.